神经重症与非神经重症患者的通气管理:PRIME数据库的汇总分析
本研究为PRIME数据库的事后汇总分析,纳入三项前瞻性观察研究的个体数据,排除初始通气时已存在ARDS的患者,共3848例(神经重症1702例,非神经重症1920例)。神经重症患者在初始和48小时评估时均接受更低的潮气量、PEEP、FiO2、驱动压、机械功率和通气比,呼吸系统顺应性更高。神经重症患者ARDS诊断率更高(8.7% vs 3.9%,p<0.001),但ICU死亡率更低(14.3% vs 22.8%,p<0.001)。在神经重症患者中,发生ARDS者接受更低的潮气量、更高的FiO2、更高的驱动压和机械功率;按预测体重标准化的潮气量与ARDS发生独立相关。
要点
- 神经重症患者接受更低的潮气量、PEEP和FiO2,且驱动压、机械功率和通气比更低,呼吸系统顺应性更高。
- 神经重症患者ARDS诊断率高于非神经重症患者(8.7% vs 3.9%,p<0.001),但ICU死亡率更低(14.3% vs 22.8%,p<0.001)。
- 在神经重症患者中,发生ARDS者接受更低的潮气量、更高的FiO2、更高的驱动压和机械功率。
- 按预测体重标准化的潮气量与神经重症患者ARDS发生独立相关。
- 神经重症与非神经重症患者的通气设置差异在初始和48小时评估时均持续存在。
适用人群与场景
- 纳入PRIME数据库的三项前瞻性观察研究(PRoVENT、PRoVENT-iMiC、ENIO)的个体患者数据,排除初始通气时已存在ARDS的患者。
- 共3848例患者,其中神经重症1702例,非神经重症1920例。
- 场景为重症监护病房,包括神经ICU和普通ICU。
诊断标准与关键阈值
- ARDS诊断依据原文未提及具体标准。
处置流程与药物剂量
- 原文未提及具体的通气管理流程或药物剂量。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:三项前瞻性观察研究的事后汇总分析(PRIME数据库),共3848例患者(神经重症1702例,非神经重症1920例)。
- 神经重症患者接受更低的潮气量、PEEP和FiO2,以及更低的驱动压、机械功率和通气比,呼吸系统顺应性更高,差异在初始和48小时评估时均一致。
- 主要终点:神经重症患者ARDS诊断率更高(8.7% vs 3.9%,p<0.001)。
- 次要终点:神经重症患者ICU死亡率更低(14.3% vs 22.8%,p<0.001)。
- 在神经重症患者中,发生ARDS者接受更低的潮气量、更高的FiO2、更高的驱动压和机械功率;按预测体重标准化的潮气量与ARDS发生独立相关。
证据类型、等级与局限
- 证据类型:三项前瞻性观察研究的事后汇总分析。
- 局限:事后分析,观察性设计,可能存在混杂;原文未提及具体局限。
对床旁实践的改变
- 神经重症患者的通气管理实践与非神经重症患者不同,需关注潮气量、PEEP和FiO2的设置。
- 神经重症患者ARDS诊断率较高,应警惕ARDS的发生。
- 按预测体重标准化的潮气量与神经重症患者ARDS发生独立相关,提示潮气量设置可能影响ARDS风险。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To describe ventilatory management in neurocritical care and non-neurocritical care patients and determine whether specific ventilator settings are associated with development of acute respiratory distress syndrome (ARDS) and mortality in neurocritical care patients. The primary endpoint was a diagnosis of ARDS after initiation of invasive ventilation; one secondary endpoint was ICU mortality.
DATA SOURCES: Post hoc pooled analysis of harmonized individual patient data from three recent prospective observational studies combined into the PRIME database.
STUDY SELECTION: PRIME is a harmonized pooled database comprising individual patient data from three recent prospective observational studies on ventilatory management in critically ill patients: "PRactice of VENTilation in critically ill patients without ARDS" (PRoVENT), "PRactice of VENTilation in critically ill patients in Middle-income Countries" (PRoVENT-iMiC), and "Extubation strategies in Neuro-ICU patients and associations with Outcomes" (ENIO). We excluded patients with ARDS at the start of ventilation.
DATA EXTRACTION: Demographic and clinical characteristics, ventilator settings, respiratory variables, arterial blood gas values, and clinical outcomes were extracted from the harmonized PRIME database. Derived ventilation parameters included tidal volume normalized to predicted body weight, driving pressure, respiratory system compliance, mechanical power, ventilatory ratio, and Pao2/Fio2 ratio.
DATA SYNTHESIS: This analysis included 3848 patients, including 1702 neurocritical care and 1920 non-neurocritical care patients. Based on recorded ventilatory variables, neurocritical care patients received lower median tidal volumes (Vts), positive end-expiratory pressure, and Fio2. They had lower median driving pressure (ΔP), mechanical power (MP) of ventilation, and ventilatory ratio, as well as higher respiratory system compliance compared with non-neurocritical care patients. These differences were consistently observed at both assessed time points. ARDS was diagnosed more frequently in neurocritical care patients than in non-neurocritical care patients (8.7% vs. 3.9%; p < 0.001), while ICU mortality was lower (14.3% vs. 22.8%; p < 0.001). Among neurocritical care patients, those who developed ARDS were ventilated with lower median Vt and higher Fio2 and had higher median ΔP and MP. Vt normalized for predicted body weight in neurocritical care patients was independently associated with the development of ARDS.
CONCLUSIONS: In this cohort, ventilatory management at the initial and 48-hour assessments differed between neurocritical care and non-neurocritical care patients, particularly with respect to key ventilator settings like Vt, positive end-expiratory pressure, and Fio2. In neurocritical care patients, ARDS was more often diagnosed than in non-neurocritical care patients.
参考来源
- Serafini SC, Cinotti R, Asehnoune K, et al. Ventilatory Management in Neurocritical Versus Non-Neurocritical Care Patients: A Pooled Analysis From the PRIME Database. Crit Care Med. 2026. PMID: 42878609. doi:10.1097/CCM.0000000000007385
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。